Search and filter adverse-event reports.
1,929,324 reports(725 ms)
Inappropriate Dose Administered; Inappropriate Dose Administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult use of a child product in a 32-year-old male patient who received HAV (Havrix…
inflammation of optic nerve on their right eye; asthma exacerbation ,asthma flare, asthma was worse, with chest pain, shortness of breath; pain at the injection site; This serious case was reported by a nurse via call center representative and described the oc…
administered a late second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 60-year-old female patient who received HAB (Twinrix) for prophyl…
Patient had chills and headache. Went to medical facility where tremors resolved. Headache resolved with tylenol. Woke up 3/18/2026 with headache, vomiting, stomach pain. Patient will follow up at 9:40am 3/18/2026 with PCP.
The patient received MCV4. The patient was scheduled for Tdap.
Men B vaccination given to student prior to age 16.
Men B vaccination given to student prior to age 16.
Sore, stiffness in arm, mild fever with pain. Discussed home care. Attempted to call mom on 3/18/2026 unable to reach to follow up.
Men B vaccination given to student prior to age 16.
Men B vaccination given to student prior to age 16.
Men B vaccination given to student prior to age 16.
Men B vaccination given to student prior to age 16.
Developed a large red warm area about 5-6 inches below injection site the day after injection. Lasted around a week and a half. Area was tender. Used Benadryl cream on the area and took Tylenol.
Rash
Autistic; This spontaneous report was received from a Physician and refers to a Child patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. T…
22% circulating monoclonal plasma cells; The initial case was missing the following minimum criteria: No AE Upon receipt of follow-up information on (11Mar2026), this case now contains all required information to be considered valid. This is a literature repo…
Spikevax administered after beyond use date (1/2/26). No adverse event reported and patient agreeable to return for re-administration of vaccine.
Eczema onset and has suffered ever since. Stopped all vaccinations.
Spikevax administered after beyond use date (1/2/26). No adverse event reported and patient agreeable to return for re-administration of vaccine.
Spikevax administered after beyond use date (1/2/26). No adverse event reported and patient agreeable to return for re-administration of vaccine.